ViroGates A/S (CPH:VIRO)
Denmark
· Delayed Price · Currency is DKK 15.45
-0.20 (-1.28%)
At close: Dec 5, 2025
ViroGates Revenue
ViroGates had revenue of 1.67M DKK in the quarter ending September 30, 2025, a decrease of -44.23%. This brings the company's revenue in the last twelve months to 8.11M, up 11.88% year-over-year. In the year 2024, ViroGates had annual revenue of 7.14M with 2.22% growth.
Revenue (ttm)
8.11M
Revenue Growth
+11.88%
P/S Ratio
17.68
Revenue / Employee
1.16M
Employees
10
Market Cap
143.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.14M | 155.00K | 2.22% |
| Dec 31, 2023 | 6.99M | -8.21M | -54.02% |
| Dec 31, 2022 | 15.20M | 6.95M | 84.27% |
| Dec 31, 2021 | 8.25M | 2.89M | 54.03% |
| Dec 31, 2020 | 5.35M | 1.77M | 49.47% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 315.60B |
| Coloplast | 27.87B |
| Genmab | 24.48B |
| ALK-Abelló | 6.08B |
| Demant | 22.59B |
| H. Lundbeck | 24.08B |
| Zealand Pharma | 9.16B |
| Ambu A/S | 6.04B |